Common use of Accounting and Disclosure Controls Clause in Contracts

Accounting and Disclosure Controls. The Company and each of its Subsidiaries maintain effective internal control over financial reporting (as defined under Rule 13-a15 and 15d-15 under the Exchange Act); a system of internal accounting controls sufficient to provide reasonable assurances that (A) transactions are executed in accordance with management’s general or specific authorization; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (C) access to assets is permitted only in accordance with management’s general or specific authorization; and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described in the General Disclosure Package and the Prospectus, since the end of the Company’s most recent audited fiscal year, there has been (1) no material weakness in the Company’s internal control over financial reporting (whether or not remediated) and (2) no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company maintains an effective system of disclosure controls and procedures (as defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act Regulations) that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding disclosure.

Appears in 6 contracts

Samples: Underwriting Agreement (Hudson Technologies Inc /Ny), Underwriting Agreement (Synthetic Biologics, Inc.), Placement Agency Agreement (Synthetic Biologics, Inc.)

AutoNDA by SimpleDocs

Accounting and Disclosure Controls. The Company (individually and each on a consolidated basis) and its subsidiaries maintain systems of its Subsidiaries maintain effective "internal control over financial reporting reporting" (as defined under in Rule 13-a15 13a-15(f) of the Securities Exchange Act of 1934, as amended, and 15d-15 under the rules and regulations of the Commission thereunder (collectively, the "Exchange Act")), that complies with the requirements of the Exchange Act); a system of internal accounting controls Act and has been designed by the Company's principal executive officer and principal financial officer, or under their supervision, sufficient to provide reasonable assurances that assurance that: (Ai) transactions are executed in accordance with management’s 's general or specific authorizationauthorizations; (Bii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP U.S. generally accepted accounting principles and to maintain accountability for assetsasset accountability; (Ciii) access to assets is permitted only in accordance with management’s 's general or specific authorization; and (Div) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described in the General Disclosure Package and the Prospectus, since the end of the The Company’s most recent audited fiscal year, there has been (1) no material weakness in the Company’s 's internal control over financial reporting (whether or is effective and the Company is not remediated) and (2) aware of any material weakness in its internal control over financial reporting. Since the date of the latest audited financial statements of the Company included in the Prospectus, there has been no change in the Company’s 's internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s 's internal control over financial reporting. The Company maintains an effective system of disclosure controls and procedures (as such term is defined in Rule 13a-15 and Rule 15d-15 13a-15(e) under the Exchange Act RegulationsAct) that are comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that material information required relating to be disclosed by the Company in the reports that it files or submits under the Exchange Act and its subsidiaries is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and is accumulated and communicated made known to the Company’s management, including its 's principal executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding disclosureby others within those entities; and such disclosure controls and procedures are effective.

Appears in 1 contract

Samples: Underwriting Agreement (Aircastle LTD)

AutoNDA by SimpleDocs

Accounting and Disclosure Controls. The Company and each of its Subsidiaries maintain effective internal control over financial reporting (as defined under Rule 13-a15 and 15d-15 under the Exchange Act); a system of internal accounting controls sufficient to provide reasonable assurances that (Ai) transactions are executed in accordance with management’s general or specific authorization; (Bii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (Ciii) access to assets is permitted only in accordance with management’s general or specific authorization; and (Div) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described in the General Disclosure Package and the Prospectus, since the end of the Company’s most recent audited fiscal year, there has been (1) no material weakness in the Company’s internal control over financial reporting (whether or not remediated) and (2) no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company maintains an effective system of disclosure controls and procedures (as defined in Rule 13a-15 and Rule 15d-15 under the Exchange Act Regulations) that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding disclosure.

Appears in 1 contract

Samples: Underwriting Agreement (Synthetic Biologics, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.